Advertisement
Home Tags Cancer: Mouth

Tag: Cancer: Mouth

Human papillomavirus (HPV)-16 detection is tied to incidence of oropharyngeal squamous cell carcinoma; and other HPVs

Research Suggests Broader Role for HPV in HNSCC Etiology

HPV-16 and other HPVs, including γ11- and γ12-HPV species and β1-HPV-5 type, all implicated
For patients with oral cancer

Fluorescence Visualization-Guided Sx Efficacious in Oral CA

Surgery reduces local recurrence in patients with squamous cell carcinoma, high-grade lesions
There is geographic variation in the proportion of head and neck cancers attributable to human papillomavirus

Geographic Variation in HPV Oropharyngeal Cancer Prevalence

HPV-positive oropharyngeal cancer prevalence varies between Western Europe and Eastern Europe, Asia
For patients with head and neck cancer treated with intensity-modulated radiation therapy

Provider Volume Affects Outcome in IMRT for Head, Neck Cancer

Improved survival for patients treated by higher-volume radiation oncologists
For patients with head and neck squamous cell carcinoma

Time to Tx Initiation Impacts Survival in Head, Neck Cancer

Lower overall survival for time to treatment initiation of more than 46 to 52 days
Head and neck cancer patients may be at increased risk for suicide

Suicide Risk Up for Head, Neck Cancer Patients

Dependence on breathing tubes, feeding tubes might play a part in despair
Specific loss of heterozygosity is a marker for oral cancer risk

Loss of Heterozygosity Validated As Marker for Oral Cancer

EGFR inhibitor erlotinib doesn't improve cancer-free survival in high-risk LOH-positive patients
Neuromuscular electrical stimulation does not add benefit to traditional swallow exercises for patients experiencing dysphagia after treatment for head and neck cancer

Neuromuscular Stimulation Doesn’t Aid Dysphagia Patients

Combining NMES with swallow exercises in head and neck cancer patients not helpful
A statistical tool can accurately estimate an individual patient's risk of developing a major complication after surgery for oral cavity squamous cell carcinoma

Statistical Tool Predicts Risk of Major Post-Op Complications

Tool validated in patients treated for oral cavity squamous cell carcinoma
For patients with incurable head and neck cancer

High-Dose Hypofractionated RT Palliative in Head, Neck Cancer

Meaningful palliative effect for 63 percent of patients, lasting for median of 4.6 months